These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Wells DJ; Wells KE; Asante EA; Turner G; Sunada Y; Campbell KP; Walsh FS; Dickson G Hum Mol Genet; 1995 Aug; 4(8):1245-50. PubMed ID: 7581360 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy for muscular dystrophy - a review of promising progress. Gregorevic P; Chamberlain JS Expert Opin Biol Ther; 2003 Aug; 3(5):803-14. PubMed ID: 12880380 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy for muscular disease. Johnston N Drug Discov Today; 2004 Sep; 9(18):777. PubMed ID: 15364061 [No Abstract] [Full Text] [Related]
15. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557 [TBL] [Abstract][Full Text] [Related]
16. Retroviral-mediated gene transfer into murine and human skeletal muscle for the correction of dystrophin deficiency. Fassati A; Serpente P; Wells DJ; Walsh FS; Dickson G Biochem Soc Trans; 1996 May; 24(2):275S. PubMed ID: 8736933 [No Abstract] [Full Text] [Related]